Results 31 to 40 of about 230,221 (297)

A flow cytometry-based assay for quantifying non-plaque forming strains of yellow fever virus. [PDF]

open access: yesPLoS ONE, 2012
Primary clinical isolates of yellow fever virus can be difficult to quantitate by standard in vitro methods because they may not form discernable plaques or induce a measurable cytopathic effect (CPE) on cell monolayers. In our hands, the Dakar strain of
Erika Hammarlund   +6 more
doaj   +1 more source

Bioavailability, Antipsoriatic Efficacy and Tolerability of a New Light Cream with Mometasone Furoate 0.1% [PDF]

open access: yes, 2012
Mometasone furoate, a potent glucocorticoid (class III) with a favorable benefit/risk ratio, has emerged as a standard medication for the treatment of inflammatory skin disorders.
Ayres JW   +30 more
core   +1 more source

Evaluation of Virus Inactivation by Formaldehyde to Enhance Biosafety of Diagnostic Electron Microscopy

open access: yesViruses, 2015
Formaldehyde (FA) fixation of infectious samples is a well-established protocol in diagnostic electron microscopy of viruses. However, published experimental data that demonstrate virus inactivation by these fixation procedures are lacking.
Lars Möller   +5 more
doaj   +1 more source

In vitro activity of six antiviral drugs against equid alphaherpesvirus type 1 indicates ganciclovir as promising drug for in vivo studies

open access: yesCiência Rural, 2018
: Equid alphaherpesvirus type 1 (EHV-1) is distributed worldwide and is a major agent of abortion, respiratory and neurological disease in horses. No specific treatment is available for EHV-1 infection, yet the potential of antiviral therapy has been ...
Amanda Lovato de Oliveira   +4 more
doaj   +1 more source

Therapeutic efficacy of favipiravir against Bourbon virus in mice [PDF]

open access: yes, 2019
Bourbon virus (BRBV) is an emerging tick-borne RNA virus in the orthomyxoviridae family that was discovered in 2014. Although fatal human cases of BRBV have been described, little is known about its pathogenesis, and no antiviral therapies or vaccines ...
Bailey, Thomas   +11 more
core   +3 more sources

Ingredients Acting as a Physical Barrier for the Prevention and Treatment of the Rhinovirus Infection

open access: yesApplied Sciences, 2020
Although the common cold, usually caused by human rhinoviruses, is responsible for enormous damage to the economy and health every year, there are hardly any treatment options or prophylaxis for rhinovirus infections.
Lisa-Marie Sittek   +2 more
doaj   +1 more source

Differentiation enhances Zika virus infection of neuronal brain cells. [PDF]

open access: yes, 2018
Zika virus (ZIKV) is an emerging, mosquito-borne pathogen associated with a widespread 2015-2016 epidemic in the Western Hemisphere and a proven cause of microcephaly and other fetal brain defects in infants born to infected mothers. ZIKV infections have
Bouquet, Jerome   +6 more
core   +3 more sources

Viral Plaque Assay v1 [PDF]

open access: yes, 2020
This is part 3.6 of the "Study of MAIT Cell Activation in Viral Infections In Vivo" collection of protocols. Collection Abstract: MAIT cells are abundant, highly evolutionarily conserved innate-like lymphocytes expressing a semi-invariant T cell receptor (TCR), which recognizes microbially derived small intermediate molecules from the riboflavin ...
Timothy S C Hinks   +7 more
openaire   +1 more source

Spectrochemical characterization of Vero cell line against PPR virus infection

open access: yesJournal of Advanced Biotechnology and Experimental Therapeutics, 2019
An in vitro virus infectivity assay based on the newly introduced spectrochemical method was performed using Peste des Petits Ruminants (PPR) virus infected Vero cell line as a model infection.
Md. Mizanur Rahman   +4 more
doaj   +1 more source

The Conditions of Primary Infection Define the Load of Latent Viral Genome in Organs and the Risk of Recurrent Cytomegalovirus Disease [PDF]

open access: yes, 1994
Recurrence of cytomegalovirus (CMV) from latency is a frequent cause of disease in immunocompromised patients. To date, there is no explanation for the diversity in the clinical manifestations.
Balthesen, Monika   +5 more
core   +4 more sources

Home - About - Disclaimer - Privacy